10-K: Vynleads Faces Going Concern Doubt Amid Zero Revenue

Vynleads, Inc. reported zero revenue for 2025 and 2024, a widening working capital deficit, and substantial doubt about its ability to continue as a going concern, despite a strategic shift to an AI-enabled subscription platform.

Summary

• Vynleads, Inc. reported zero revenue for both the fiscal years ended December 31, 2025, and December 31, 2024.
• The company incurred a net loss of $255,066 in 2025, a slight improvement from $261,192 in 2024.
• An accumulated deficit of $3,040,596 was reported as of December 31, 2025.
• The working capital deficit worsened to $(352,431) in 2025 from $(227,365) in 2024.
• Net cash used in operating activities was $(108,860) in 2025, an improvement from $(112,390) in 2024.
• The company's cash balance decreased to $44,628 at the end of 2025 from $68,988 at the end of 2024.
• Management requires approximately $5,500,000 in additional working capital over the next 12 months to fund business objectives, including platform development, product expansion, and marketing.
• The company is transitioning to an app-based subscription model for its Done With Diabetes platform, incorporating AI-enabled coaching and agentic workflows.
• A material weakness in internal control over financial reporting was identified due to limited personnel and lack of segregation of duties.
• The company's common stock trades on OTCQB under the symbol VYND, with a price of $0.43 as of March 24, 2026.

Sentiment

Score: 1

Explanation: StockSavvy.ai views this filing with extremely negative sentiment due to zero revenue, significant and worsening financial deficits, a going concern warning, and identified material weaknesses in internal controls, indicating severe operational and financial distress.

Positives

• Net loss slightly decreased to $255,066 in 2025 from $261,192 in 2024.
• Net cash used in operating activities improved to $(108,860) in 2025 from $(112,390) in 2024.
• The company is strategically repositioning its go-to-market around an app-based subscription offering with AI-enabled coaching and agentic AI workflows, aiming for recurring digital engagement and scalability.
• Cost of revenue decreased by 56.36% to $6,499 in 2025.
• Interest expense decreased significantly in 2025 due to a large portion of debt being converted to equity in FY 2024.

Negatives

• Reported zero revenue for both the fiscal years ended December 31, 2025, and December 31, 2024.
• Experienced recurring operating losses since inception, resulting in an accumulated deficit of $3,040,596 as of December 31, 2025.
• Working capital deficit worsened to $(352,431) in 2025 from $(227,365) in 2024.
• Substantial doubt exists about the company's ability to continue as a going concern.
• Cash balance decreased to $44,628 at December 31, 2025, from $68,988 at December 31, 2024.
• Total current liabilities increased to $406,140 in 2025 from $314,568 in 2024.
• Several notes payable are currently in default.
• Identified a material weakness in internal control over financial reporting due to limited personnel and lack of segregation of duties.
• The company has only one employee (the CEO) and relies heavily on third-party service providers.
• The market for the company's common stock is limited and sporadic.

Risks

• The transition to an app-based subscription and platform model may not succeed in user acquisition, conversion, retention, or realizing expected operational leverage from AI.
• Business depends on sustained user engagement, retention, and perceived relevance, which may not be achieved.
• Operates in a highly competitive and rapidly evolving market with competitors possessing significantly greater resources.
• Enterprise strategy may involve long sales cycles, additional requirements, and uncertain conversion, potentially leading to wasted resources.
• Use of artificial intelligence, including agentic and agent-to-agent workflows, may expose the company to product, legal, and reputational risk due to inaccurate, biased, or inappropriate outputs.
• Inability to appropriately substantiate, communicate, or qualify claims regarding the platform could lead to regulatory and reputational harm.
• The evolving regulatory environment applicable to digital wellness, subscription commerce, privacy, and health-adjacent claims may become more burdensome.
• Platform, systems, or data could be compromised, unavailable, or exposed due to security incidents, vendor failures, or other events.
• Heavy reliance on third-party service providers and external platforms means limited control over their performance, security, and policies.
• Business is dependent on a small number of key personnel and external support relationships, making it vulnerable to loss of personnel or disruption in vendor relationships.
• The DWX platform vision, broader agentic architecture, and future condition-specific offerings may never be realized or may distract management from the flagship product.
• Ongoing legal dispute with a former consultant regarding promotional services and alleged non-payment of royalties, with unauthorized UCC liens filed against the company.

Future Outlook

Vynleads plans to scale its app-based subscription platform, strengthen its AI and agentic product layer, and build a broader, repeatable technology foundation. It intends to pursue enterprise distribution and sponsored deployment opportunities. The company also envisions expanding its DWX platform to additional chronic or habit-influenced conditions, such as heart disease and depression, contingent on product development, regulatory considerations, market demand, and capital availability. Management estimates requiring approximately $5,500,000 in additional working capital over the next 12 months to meet current business objectives and fund growth.

Management Comments

• Management believes [the DWX platform] may serve as a repeatable technology and content framework for additional lifestyle-first condition programs over time.
• Management believes that, if successfully implemented, specialized AI agents that can interact with members and coordinate with one another may improve responsiveness, continuity and scalability across the platform.
• Management believes this pricing model may support broad accessibility while also aligning our economics with longer-term user engagement, retention and lifetime value.
• Management believes that our combination of structured content, community workflows and AI-enabled, potentially agentic support may be relevant to organizations seeking scalable lifestyle programs without a fully labor-intensive coaching model.
• Management estimates that we require approximately $5,500,000 in additional working capital during the next 12 months in order to meet our current business objectives.

Industry Context

StockSavvy.ai notes that Vynleads operates in the highly competitive and rapidly evolving digital health and wellness market, characterized by numerous players ranging from established digital health applications and weight-management platforms to free online resources. The company's strategic pivot towards an AI-enabled subscription model and agentic AI workflows aligns with broader industry trends emphasizing personalization, scalability, and recurring revenue in health tech. However, its zero revenue and significant financial deficits place it at a severe disadvantage compared to well-funded competitors like Noom, WW (WeightWatchers), or Livongo (now part of Teladoc Health), which have substantial financial, technical, and marketing resources. The focus on metabolic health and chronic conditions is a growing segment, but Vynleads' ability to differentiate and secure enterprise partnerships against larger, more clinically validated solutions remains a critical challenge.

Comparison to Industry Standards

• Vynleads' reported zero revenue for two consecutive years is significantly below industry standards for publicly traded wellness technology companies, which typically demonstrate revenue growth, even in early stages.
• The accumulated deficit of over $3 million and a widening working capital deficit are indicative of a company struggling to achieve financial viability, contrasting sharply with successful digital health platforms that often secure substantial venture capital or demonstrate clear paths to profitability.
• The reliance on a single employee (the CEO) and heavy outsourcing is atypical for a company aiming for a scalable technology platform, especially when compared to competitors like Calm or Headspace, which have robust internal teams for product development, marketing, and operations.
• The 'going concern' warning is a critical red flag, indicating a severe financial distress level not commonly seen in thriving industry players without a clear, imminent funding solution.
• The identified material weakness in internal controls due to limited personnel is a governance concern that would be unacceptable for larger, more mature companies in the sector.

Corporate Governance

Legal Proceedings

• An ongoing dispute with a consultant (Promoter) from 2016 regarding alleged non-payment of royalties for promotional services and a book.
• The Promoter filed unauthorized Uniform Commercial Code (UCC) financing statements (liens) against the company and its officers/directors.
• The company disputes the claims, believing all royalties were paid, and is actively pursuing actions to remove the remaining unauthorized UCC liens.

Related Party Transactions

• Mr. Sergei Stetsenko, a director, converted notes payable totaling $44,427 (principal and accrued interest) into common stock on October 31, 2024.
• Mr. Alex J. Mannine, the Chief Executive Officer, voluntarily waived his annual salary of $130,000 for both 2025 and 2024, which was treated as an in-kind contribution of service.

Stakeholder Impact

• Shareholders face significant risk due to the "going concern" warning, zero revenue, widening deficits, and the need for substantial future capital raises, which could dilute existing shares. The limited and sporadic market for common stock also impacts liquidity.
• Creditors face heightened risk as notes payable are increasing, and several are in default.
• Employees (currently only one, the CEO) indicate high reliance on external contractors and potential instability if funding is not secured.
• Customers may experience uncertainty regarding long-term service delivery due to the company's financial instability, despite the strategic shift to an app-based subscription model and AI-enabled coaching.
• Suppliers/Vendors face potential payment risks given the company's financial health and increasing liabilities.

Next Steps

• Scale the app-based subscription platform.
• Strengthen the AI and agentic product layer.
• Build a broader, repeatable technology foundation.
• Pursue enterprise distribution and sponsored deployment opportunities.
• Develop new indicators for the Lifestyle Blueprint platform.
• Add print versions of the DWD Protocol.
• Expand the supplement product line.
• Offer additional subscription content.
• Raise approximately $5,500,000 in additional working capital within the next 12 months.
• Hire additional personnel to expand the finance and accounting department to mitigate internal control weaknesses.
• Continue efforts to remove remaining unauthorized UCC liens.
• Potentially expand the DWX platform to address heart disease and depression.

Key Dates

Recommendation

The company reported zero revenue for two consecutive years (2024 and 2025), has a substantial and worsening working capital deficit, and auditors have issued a 'going concern' warning, indicating significant doubt about its ability to continue operations. It requires $5.5 million in additional capital with no firm commitments. These factors, combined with a material weakness in internal controls and several defaulted notes payable, present an extremely high-risk profile with no clear path to profitability or sustainable operations. The stock is highly speculative and faces imminent financial challenges.

Keywords

Vynleads, VYND, SEC 10-K, Annual Report, Wellness Technology, Metabolic Health, Done With Diabetes, AI Coaching, Subscription Platform, Going Concern, Financial Losses, Working Capital Deficit, Capital Raise, Digital Health, Corporate Governance, Risk Factors, Internal Controls, OTC Markets